Fine-mapping CASP8 risk variants in breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 1, 2012, Pages 176-181

  Camp, Nicola J ^a   Parry, Marina ^c   Knight, Stacey ^a   Abo, Ryan ^e   Elliott, Graeme ^f   Rigas, Sushilaben H ^c   Balasubramanian, Sabapathy P ^d   Reed, Malcolm W R ^d   McBurney, Helen ^f   Latif, Ayse ^f   Newman, William G ^f   Cannon Albright, Lisa A ^a,b   Gareth Evans, D ^f   Cox, Angela ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Department of Oncology   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e MAYO GRADUATE SCHOOL   (United States)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CASPASE 8; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84855501003     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0845     Document Type: Article

References (21)

1. Zhang B, Beeghly-Fadiel A, Long J, Zheng W. Genetic variants associated with breast- cancer risk:comprehensiveresearchsynopsis,metaanalysis, and epidemiological evidence. Lancet Oncol 2011;12:477-88.
2. Peng S, Lü B, Ruan W, Zhu Y, Sheng H, Lai M. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Res Treat 2011;127:309-24.
3. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, et al.Acommon coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007;39:352-8. (Pubitemid 46328496)
4. Sergentanis TN, Economopoulos KP. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010;120:229-34.
5. Yin M, Yan J, Wei S, Wei Q. CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies. Carcinogenesis 2010;31:850-7.
6. Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, et al. A six-nucleotide insertion-deletion polymorphismin the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 2007;39:605-13. (Pubitemid 46676113)
7. Frank B, Rigas SH, Bermejo JL, Wiestler M, Wagner K, Hemminki K, et al. The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat 2008;111: 139-44. (Pubitemid 352009221)
8. Haiman CA, Garcia RR, Kolonel LN, Henderson BE, Wu AH, Le Marchand L.Apromoter polymorphism in theCASP8 gene is not associated with cancer risk. Nat Genet 2008;40:259-60. (Pubitemid 351311777)
9. Li C, Lu J, Liu Z, Wang L-E, Zhao H, El-Naggar AK, et al. The sixnucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck. Cancer Prev Res 2010;3:246-52.
10. Frank B, Hemminki K, Wappenschmidt B, Meindl A, Klaes R, Schmutzler RK, et al. Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 2006;27:606-9. (Pubitemid 43372889)
11. Rogers KM, Thomas M, Galligan L, Wilson TR, Allen WL, Sakai H, et al. Cellular FLICE-inhibitory protein regulates chemotherapy-induced apoptosis in breast cancer cells. Mol Cancer Ther 2007; 6:1544-51. (Pubitemid 46954021)
12. Shephard ND, R Abo, Rigas SH, Frank B, Lin WY, Brock IW, et al. A breast cancer risk haplotype in the caspase-8 gene. Cancer Res 2009;69:2724-8.
13. MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MW, Pharoah PD, et al. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2004;96: 1866-9. (Pubitemid 40081324)
14. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-20. (Pubitemid 38085242)
15. Available from: HapMap http://hapmap.ncbi.nlm.nih.gov/;
16. NIEHS http://egp.gs.washington.edu.
17. Curtin K, Wong J, Allen-Brady K, Camp NJ. PedGenie: meta genetic association testing in mixed family and case-control designs. BMC Bioinformatics 2007;8:448.
18. Abo R, Knight S, Wong J, Cox A, Camp NJ. hapConstructor: automatic construction and testing of haplotypes in a Monte Carlo framework. Bioinformatics 2008;24:2105-7.
19. Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, Andresen PA, et al. Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 2011;43:1108-13.
20. Enjuanes A, Benavente Y, Bosch F, Martín-Guerrero I, Colomer D, Pérez-Alvarez S, et al. Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. Cancer Res 2008;68:10178-86.
21. Couch FJ, Wang X, McWilliams RR, Bamlet WR, de Andrade M, Petersen GM. Association of breast cancer susceptibility variants with risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2009;18: 3044-8.